Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Blue Jet HealthcareBOM:544009 +0.86%64 Dividend Yield % is 0.21% as of Jul. 21, 2026, which is 11% above its 10-year median of 0.19. GuruFocus rates BOM:544009 with a GF Score™ of 64/100 and a GF Value™ of ₹562.05 (Fairly Valued). The stock has 10 warning signs investors should review. Among 153 Biotechnology companies, Blue Jet Healthcare ranks worse than 92.81% on this metric.
As of today (2026-07-21), the Trailing Annual Dividend Yield of Blue Jet Healthcare is 0.21%.
The historical rank and industry rank for Blue Jet Healthcare's Dividend Yield % or its related term are showing as below:
BOM:544009'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.1 Med: 0.19 Max: 0.35
Current: 0.21
During the past 6 years, the highest Dividend Yield of Blue Jet Healthcare was 0.35%. The lowest was 0.10%. And the median was 0.19%.
BOM:544009's Dividend Yield % is ranked worse than 92.81% of 153
companies
in the Biotechnology industry
Industry Median: 1.31
vs BOM:544009: 0.21
During the past 12 months, Blue Jet Healthcare's average Dividends Per Share Growth Rate was 20.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Blue Jet Healthcare (BOM:544009) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Blue Jet Healthcare Dividend Yield % Related Terms
Blue Jet Healthcare Dividend Yield % Historical Data
* Premium members only.
The historical data trend for Blue Jet Healthcare's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544009 vs VRTX, REGN, ALNY: Dividend Yield % Comparison
For the Biotechnology subindustry, Blue Jet Healthcare's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Blue Jet Healthcare Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Blue Jet Healthcare's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Blue Jet Healthcare's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Blue Jet Healthcare Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
INR 1.200000
2025-09-19
2025-09-19
2025-10-07
Cash Dividend
annually
INR:INR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Blue Jet Healthcare's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Blue Jet Healthcare (BOM:544009) has a Dividend Yield % of 0.21% as of Jul. 21, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Blue Jet Healthcare and its competitors. This is 11% above median its historical median of 0.19. Over the past decade, Blue Jet Healthcare's Dividend Yield % has ranged from 0.10 to 0.35. According to the industry distribution chart, Blue Jet Healthcare ranks #142 out of 153 companies in the Biotechnology industry, placing it in the top 92.8%.
Is Blue Jet Healthcare's Dividend Yield % too high?
Blue Jet Healthcare's current Dividend Yield % of 0.21% is 11% above median its 10-year median of 0.19. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 0.35. The Biotechnology industry median Dividend Yield % is 1.31. Blue Jet Healthcare's value of 0.21% is 84% below this industry median. Based on the distribution chart, Blue Jet Healthcare ranks #142 out of 153 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Blue Jet Healthcare has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Blue Jet Healthcare's Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Blue Jet Healthcare ranks #142 out of 153 companies for Dividend Yield %. This places Blue Jet Healthcare in the lower half of its industry. The industry median Dividend Yield % is 1.31. Blue Jet Healthcare's value of 0.21% is 84% below this benchmark. Historically, Blue Jet Healthcare's own Dividend Yield % has ranged from 0.10 to 0.35 over the past decade. While the company's 10-year median is 0.19 vs. the industry median of 1.31, Blue Jet Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.31, based on 153 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Blue Jet Healthcare's current Dividend Yield % of 0.21% is 84% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Blue Jet Healthcare and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Blue Jet Healthcare's current Dividend Yield % is 0.21%, which is 11% above median its own 10-year median of 0.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blue Jet Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Blue Jet Healthcare (BOM:544009) is currently considered Fairly Valued. The stock's GF Value™ is ₹562.05, compared to a current price of ₹589.75 — trading 4.9% above its estimated fair value. The current Dividend Yield % is 0.21%, which is 11% above median its 10-year median of 0.19 and 84% below the Biotechnology industry median of 1.31. Blue Jet Healthcare's overall GF Score™ is 64/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Blue Jet Healthcare (BOM:544009), the current Dividend Yield % is 0.21% as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Blue Jet Healthcare (BOM:544009) Overvalued in 2026?
Based on GuruFocus' analysis, Blue Jet Healthcare stock appears to be overvalued.
The current stock price of ₹589.75 is trading 4.9% above its estimated GF Value™ of ₹562.05.
GuruFocus considers Blue Jet Healthcare to be Fairly Valued.
Key valuation signals for BOM:544009:
Dividend Yield %: 0.21% (11% above median its 10-year median of 0.19)
GF Value™: ₹562.05 vs. price of ₹589.75 (4.9% above fair value)
Industry Position: 84% below the Biotechnology median (#142 of 153)
No single metric tells the full story. See the BOM:544009 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Blue Jet Healthcare Ltd is engaged in manufacturing of Pharma Intermediate, APIs used in Pharmaceutical and Healthcare Products. The operations of the company are organized in three product categories which are contrast media intermediates, artificial sweeteners, pharma intermediates, and active pharmaceutical ingredients. Geographically, it operates in Norway, France, India and Rest of the World.
64GF Score
Get the complete analysis for BOM:544009
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544009 has been successfully added to your 
